Acuta Capital Partners, LLC Chimerix Inc Transaction History

Acuta Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $1.1 Million - $1.51 Million	-210,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $1.78 Million - $2.62 Million	-299,164 Reduced 58.76%	210,000 $1.3 Million
Q2 2021 Aug 16, 2021	SELL	$7.54 - $9.79 $1.5 Million - $1.94 Million	-198,666 Reduced 28.07%	509,164 $4.07 Million
Q1 2021 May 17, 2021	BUY	$4.76 - $11.25 $3.37 Million - $7.96 Million	707,830 New	707,830 $6.82 Million
Q3 2019 Nov 14, 2019	SELL	$1.93 - $4.21 $540,400 - $1.18 Million	-280,000 Closed	0 $0

Q2 2019 Aug 14, 2019	BUY	$2.05 - $4.32 $574,000 - $1.21 Million	280,000 New	280,000 $1.21 Million

29.6M

18.9K

40.9K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.